SERPINA1 and cholangiocarcinoma: Recently, we demonstrated that the serum levels of oxidized A1AT were increased in liver fluke infected subjects with advanced periductal fibrosis and in cholangiocarcinoma patients compared with normal subjects, suggesting that the oxidized A1AT can be used as a biomarker for predicting the risk of liver fluke-associated cholangiocarcinoma [93].